Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life
Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population. Methods. Data were obtained by means of a posta...
Saved in:
| Published in | PeerJ (San Francisco, CA) Vol. 1; p. e98 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
PeerJ. Ltd
09.07.2013
PeerJ, Inc PeerJ Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2167-8359 2167-8359 |
| DOI | 10.7717/peerj.98 |
Cover
| Abstract | Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population. Methods. Data were obtained by means of a postal survey administered to 3001 randomly selected adults. After two reminders response rate was 44.3%. Measures of depression and general anxiety were the 9-item Patient Health Questionnaire Depression Scale (PHQ-9) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). The PHQ-9 identified participants who had experienced clinically significant depression (PHQ-9 ≥ 10), and who had a diagnosis of major depression (defined by using a PHQ-9 scoring algorithm). Clinically significant anxiety was defined as having a GAD-7 score ≥ 8. To specifically measure generalized anxiety disorder, the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) was used with an established cut-off. Health-related quality of life was measured using the EuroQol (EQ-5D). Experiences of treatments for psychiatric disorders were also assessed. Results. Around 17.2% (95% CI: 15.1-19.4) of the participants were experiencing clinically significant depression (10.8%; 95% CI: 9.1-12.5) and clinically significant anxiety (14.7%; 95% CI: 12.7-16.6). Among participants with either clinically significant depression or anxiety, nearly 50% had comorbid disorders. The point prevalence of major depression was 5.2% (95% CI: 4.0-6.5), and 8.8% (95% CI: 7.3-10.4) had GAD. Among those with either of these disorders, 28.2% had comorbid depression and GAD. There were, generally, significant gender differences, with more women having a disorder compared to men. Among those with depression or anxiety, only between half and two thirds had any treatment experience. Comorbidity was associated with higher symptom severity and lower health-related quality of life. Conclusions. Epidemiological data from the Swedish community collected in this study provide point prevalence rates of depression, anxiety disorders and their comorbidity. These conditions were shown in this study to be undertreated and associated with lower quality of life, that need further efforts regarding preventive and treatment interventions. |
|---|---|
| AbstractList | Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population. Methods. Data were obtained by means of a postal survey administered to 3001 randomly selected adults. After two reminders response rate was 44.3%. Measures of depression and general anxiety were the 9-item Patient Health Questionnaire Depression Scale (PHQ-9) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). The PHQ-9 identified participants who had experienced clinically significant depression (PHQ-9 [greater than or equal to] 10), and who had a diagnosis of major depression (defined by using a PHQ-9 scoring algorithm). Clinically significant anxiety was defined as having a GAD-7 score [greater than or equal to] 8. To specifically measure generalized anxiety disorder, the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) was used with an established cut-off. Health-related quality of life was measured using the EuroQol (EQ-5D). Experiences of treatments for psychiatric disorders were also assessed. Results. Around 17.2% (95% CI: 15.1-19.4) of the participants were experiencing clinically significant depression (10.8%; 95% CI: 9.1-12.5) and clinically significant anxiety (14.7%; 95% CI: 12.7-16.6). Among participants with either clinically significant depression or anxiety, nearly 50% had comorbid disorders. The point prevalence of major depression was 5.2% (95% CI: 4.0-6.5), and 8.8% (95% CI: 7.3-10.4) had GAD. Among those with either of these disorders, 28.2% had comorbid depression and GAD. There were, generally, significant gender differences, with more women having a disorder compared to men. Among those with depression or anxiety, only between half and two thirds had any treatment experience. Comorbidity was associated with higher symptom severity and lower health-related quality of life. Conclusions. Epidemiological data from the Swedish community collected in this study provide point prevalence rates of depression, anxiety disorders and their comorbidity. These conditions were shown in this study to be undertreated and associated with lower quality of life, that need further efforts regarding preventive and treatment interventions. Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population. Methods. Data were obtained by means of a postal survey administered to 3001 randomly selected adults. After two reminders response rate was 44.3%. Measures of depression and general anxiety were the 9-item Patient Health Questionnaire Depression Scale (PHQ-9) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). The PHQ-9 identified participants who had experienced clinically significant depression (PHQ-9 ≥ 10), and who had a diagnosis of major depression (defined by using a PHQ-9 scoring algorithm). Clinically significant anxiety was defined as having a GAD-7 score ≥ 8. To specifically measure generalized anxiety disorder, the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) was used with an established cut-off. Health-related quality of life was measured using the EuroQol (EQ-5D). Experiences of treatments for psychiatric disorders were also assessed. Results. Around 17.2% (95% CI: 15.1-19.4) of the participants were experiencing clinically significant depression (10.8%; 95% CI: 9.1-12.5) and clinically significant anxiety (14.7%; 95% CI: 12.7-16.6). Among participants with either clinically significant depression or anxiety, nearly 50% had comorbid disorders. The point prevalence of major depression was 5.2% (95% CI: 4.0-6.5), and 8.8% (95% CI: 7.3-10.4) had GAD. Among those with either of these disorders, 28.2% had comorbid depression and GAD. There were, generally, significant gender differences, with more women having a disorder compared to men. Among those with depression or anxiety, only between half and two thirds had any treatment experience. Comorbidity was associated with higher symptom severity and lower health-related quality of life. Conclusions. Epidemiological data from the Swedish community collected in this study provide point prevalence rates of depression, anxiety disorders and their comorbidity. These conditions were shown in this study to be undertreated and associated with lower quality of life, that need further efforts regarding preventive and treatment interventions.Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population. Methods. Data were obtained by means of a postal survey administered to 3001 randomly selected adults. After two reminders response rate was 44.3%. Measures of depression and general anxiety were the 9-item Patient Health Questionnaire Depression Scale (PHQ-9) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). The PHQ-9 identified participants who had experienced clinically significant depression (PHQ-9 ≥ 10), and who had a diagnosis of major depression (defined by using a PHQ-9 scoring algorithm). Clinically significant anxiety was defined as having a GAD-7 score ≥ 8. To specifically measure generalized anxiety disorder, the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) was used with an established cut-off. Health-related quality of life was measured using the EuroQol (EQ-5D). Experiences of treatments for psychiatric disorders were also assessed. Results. Around 17.2% (95% CI: 15.1-19.4) of the participants were experiencing clinically significant depression (10.8%; 95% CI: 9.1-12.5) and clinically significant anxiety (14.7%; 95% CI: 12.7-16.6). Among participants with either clinically significant depression or anxiety, nearly 50% had comorbid disorders. The point prevalence of major depression was 5.2% (95% CI: 4.0-6.5), and 8.8% (95% CI: 7.3-10.4) had GAD. Among those with either of these disorders, 28.2% had comorbid depression and GAD. There were, generally, significant gender differences, with more women having a disorder compared to men. Among those with depression or anxiety, only between half and two thirds had any treatment experience. Comorbidity was associated with higher symptom severity and lower health-related quality of life. Conclusions. Epidemiological data from the Swedish community collected in this study provide point prevalence rates of depression, anxiety disorders and their comorbidity. These conditions were shown in this study to be undertreated and associated with lower quality of life, that need further efforts regarding preventive and treatment interventions. Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population. Methods. Data were obtained by means of a postal survey administered to 3001 randomly selected adults. After two reminders response rate was 44.3%. Measures of depression and general anxiety were the 9-item Patient Health Questionnaire Depression Scale (PHQ-9) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). The PHQ-9 identified participants who had experienced clinically significant depression (PHQ-9 ≥ 10), and who had a diagnosis of major depression (defined by using a PHQ-9 scoring algorithm). Clinically significant anxiety was defined as having a GAD-7 score ≥ 8. To specifically measure generalized anxiety disorder, the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) was used with an established cut-off. Health-related quality of life was measured using the EuroQol (EQ-5D). Experiences of treatments for psychiatric disorders were also assessed. Results. Around 17.2% (95% CI: 15.1–19.4) of the participants were experiencing clinically significant depression (10.8%; 95% CI: 9.1–12.5) and clinically significant anxiety (14.7%; 95% CI: 12.7–16.6). Among participants with either clinically significant depression or anxiety, nearly 50% had comorbid disorders. The point prevalence of major depression was 5.2% (95% CI: 4.0–6.5), and 8.8% (95% CI: 7.3–10.4) had GAD. Among those with either of these disorders, 28.2% had comorbid depression and GAD. There were, generally, significant gender differences, with more women having a disorder compared to men. Among those with depression or anxiety, only between half and two thirds had any treatment experience. Comorbidity was associated with higher symptom severity and lower health-related quality of life. Conclusions. Epidemiological data from the Swedish community collected in this study provide point prevalence rates of depression, anxiety disorders and their comorbidity. These conditions were shown in this study to be undertreated and associated with lower quality of life, that need further efforts regarding preventive and treatment interventions. Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population. Methods. Data were obtained by means of a postal survey administered to 3001 randomly selected adults. After two reminders response rate was 44.3%. Measures of depression and general anxiety were the 9-item Patient Health Questionnaire Depression Scale (PHQ-9) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). The PHQ-9 identified participants who had experienced clinically significant depression (PHQ-9 ≥ 10), and who had a diagnosis of major depression (defined by using a PHQ-9 scoring algorithm). Clinically significant anxiety was defined as having a GAD-7 score ≥ 8. To specifically measure generalized anxiety disorder, the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) was used with an established cut-off. Health-related quality of life was measured using the EuroQol (EQ-5D). Experiences of treatments for psychiatric disorders were also assessed. Results. Around 17.2% (95% CI: 15.1–19.4) of the participants were experiencing clinically significant depression (10.8%; 95% CI: 9.1–12.5) and clinically significant anxiety (14.7%; 95% CI: 12.7–16.6). Among participants with either clinically significant depression or anxiety, nearly 50% had comorbid disorders. The point prevalence of major depression was 5.2% (95% CI: 4.0–6.5), and 8.8% (95% CI: 7.3–10.4) had GAD. Among those with either of these disorders, 28.2% had comorbid depression and GAD. There were, generally, significant gender differences, with more women having a disorder compared to men. Among those with depression or anxiety, only between half and two thirds had any treatment experience. Comorbidity was associated with higher symptom severity and lower health-related quality of life. Conclusions. Epidemiological data from the Swedish community collected in this study provide point prevalence rates of depression, anxiety disorders and their comorbidity. These conditions were shown in this study to be undertreated and associated with lower quality of life, that need further efforts regarding preventive and treatment interventions. Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of depression, generalized anxiety disorder and anxiety disorders in general in the Swedish population.Methods. Data were obtained by means of a postal survey administered to 3001 randomly selected adults. After two reminders response rate was 44.3%. Measures of depression and general anxiety were the 9-item Patient Health Questionnaire Depression Scale (PHQ-9) and the 7-item Generalized Anxiety Disorder Scale (GAD-7). The PHQ-9 identified participants who had experienced clinically significant depression (PHQ-9 >= 10), and who had a diagnosis of major depression (defined by using a PHQ-9 scoring algorithm). Clinically significant anxiety was defined as having a GAD-7 score >= 8. To specifically measure generalized anxiety disorder, the Generalized Anxiety Disorder Questionnaire-IV (GAD-Q-IV) was used with an established cut-off. Health-related quality of life was measured using the EuroQol (EQ-5D). Experiences of treatments for psychiatric disorders were also assessed.Results. Around 17.2% (95% CI: 15.1-19.4) of the participants were experiencing clinically significant depression (10.8%; 95% CI: 9.1-12.5) and clinically significant anxiety (14.7%; 95% CI: 12.7-16.6). Among participants with either clinically significant depression or anxiety, nearly 50% had comorbid disorders. The point prevalence of major depression was 5.2% (95% CI: 4.0-6.5), and 8.8% (95% CI: 7.3-10.4) had GAD. Among those with either of these disorders, 28.2% had comorbid depression and GAD. There were, generally, significant gender differences, with more women having a disorder compared to men. Among those with depression or anxiety, only between half and two thirds had any treatment experience. Comorbidity was associated with higher symptom severity and lower health-related quality of life.Conclusions. Epidemiological data from the Swedish community collected in this study provide point prevalence rates of depression, anxiety disorders and their comorbidity. These conditions were shown in this study to be undertreated and associated with lower quality of life, that need further efforts regarding preventive and treatment interventions. |
| Audience | Academic |
| Author | Paxling, Björn Carlbring, Per Heedman, Åsa Johansson, Robert Andersson, Gerhard |
| Author_xml | – sequence: 1 givenname: Robert surname: Johansson fullname: Johansson, Robert organization: Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden – sequence: 2 givenname: Per surname: Carlbring fullname: Carlbring, Per organization: Department of Psychology, Stockholm University, Stockholm, Sweden – sequence: 3 givenname: Åsa surname: Heedman fullname: Heedman, Åsa organization: Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden – sequence: 4 givenname: Björn surname: Paxling fullname: Paxling, Björn organization: Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden – sequence: 5 givenname: Gerhard surname: Andersson fullname: Andersson, Gerhard organization: Department of Behavioural Sciences and Learning, Linköping University, Linköping, Sweden, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institutet, Stockholm, Sweden, Swedish Institute for Disability Research, Linköping University, Linköping, Sweden |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23862109$$D View this record in MEDLINE/PubMed https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-96837$$DView record from Swedish Publication Index https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-92823$$DView record from Swedish Publication Index http://kipublications.ki.se/Default.aspx?queryparsed=id:130454910$$DView record from Swedish Publication Index |
| BookMark | eNqFk9tq3DAQhk1JadJtoE9QDIWS0mxqSZYt9aIQkh4CgV70cCu08nhXW63kSHbSvESfubO7OW1IqHWhYfzNr0Hz63m25YOHLHtJioO6JvX7DiDOD6R4ku1QUtVjwbjcuhNvZ7spzQv8BK0KwZ5l25SJipJC7mR_j6GLkJINfj_X_o-F_hL3Ju9nYGNuwiLEiW0sZq1fJvPvF9DYNMun4CFql3ehG5zuUeADxtb3OQqeawfewLVSDm0Lps-Dz2egXT8bR8AaaPKzQbuleGhzZ1t4kT1ttUuwe7WPsp-fP_04-jo-_fbl5OjwdGyqmvdjJqWQBdNSCwaUNg1UwEFzkGVbliBlDXQyaeoJqRkzojBsQicNcNpSwzRoNspO1rpN0HPVRbvQ8VIFbdUqEeJU6dhb40ARKICIUpgWSFkxpoksuSkIyIYZifqj7O1aa_CdvrzQzt0IkkItR6RWI1JSIDtes-kCumGycfJV6jdGoDgVhEvk3z3KH9tfh6tO06AkFXTZyf7_aWcRrwSrEf-4xpFdQGPA9zjQjarNP97O1DScK1YXkhQlCuxdCcRwNkDq1cImA85pD2FIipQFmoxy7G2Uvb6HzsMQPc5YEcklr0rJqltqiv5R1rcBzzVLUXXIS8Z5XXGC1MEDFK4GFtbg42gt5jcK3twpWDswBTcsTZs2wVd3b-TmKq7fy-3RJoaUIrTK2H5lfmzBuocGvnev4FFv_APuVDkL |
| CitedBy_id | crossref_primary_10_1016_j_eurpsy_2015_06_002 crossref_primary_10_1016_j_psyneuen_2024_107094 crossref_primary_10_1080_13548506_2023_2177684 crossref_primary_10_1186_s12888_022_04237_y crossref_primary_10_1155_2015_193729 crossref_primary_10_3389_fpsyg_2025_1526181 crossref_primary_10_1080_08039488_2018_1536766 crossref_primary_10_3389_fncel_2019_00320 crossref_primary_10_1186_s40359_021_00657_9 crossref_primary_10_1186_s41155_022_00226_y crossref_primary_10_1371_journal_pone_0169623 crossref_primary_10_1016_j_jpsychires_2023_01_029 crossref_primary_10_1038_s41398_024_03003_w crossref_primary_10_3389_fpsyt_2019_00792 crossref_primary_10_7717_peerj_15346 crossref_primary_10_1016_j_invent_2014_02_001 crossref_primary_10_1186_s12889_018_6294_8 crossref_primary_10_1097_PR9_0000000000001265 crossref_primary_10_1097_AOG_0000000000002445 crossref_primary_10_2139_ssrn_4190289 crossref_primary_10_1016_j_jpainsymman_2019_09_021 crossref_primary_10_1177_0091217420906979 crossref_primary_10_1186_s12998_023_00511_2 crossref_primary_10_1186_s12875_015_0252_7 crossref_primary_10_1007_s00404_023_06917_w crossref_primary_10_3389_fpsyt_2022_933858 crossref_primary_10_1016_j_genhosppsych_2021_08_004 crossref_primary_10_1007_s41669_024_00474_x crossref_primary_10_1080_00207411_2023_2219950 crossref_primary_10_1093_humrep_dez087 crossref_primary_10_1097_AJP_0000000000000851 crossref_primary_10_1111_apa_14658 crossref_primary_10_1097_DBP_0000000000000898 crossref_primary_10_1016_j_jad_2018_09_053 crossref_primary_10_1016_j_psychres_2022_114924 crossref_primary_10_1080_00016357_2019_1661512 crossref_primary_10_1136_bmjsem_2021_001264 crossref_primary_10_1016_j_jad_2020_01_078 crossref_primary_10_3389_fpsyg_2017_01411 crossref_primary_10_1007_s10862_024_10163_y crossref_primary_10_1016_j_invent_2024_100741 crossref_primary_10_1016_j_jad_2022_11_004 crossref_primary_10_1016_j_jare_2024_03_015 crossref_primary_10_1136_bmjopen_2017_018539 crossref_primary_10_1080_00981389_2022_2091080 crossref_primary_10_3390_ejihpe10010028 crossref_primary_10_1097_NMD_0000000000001557 crossref_primary_10_1016_j_comppsych_2018_08_006 crossref_primary_10_1016_j_psychres_2021_113792 crossref_primary_10_1186_s12888_020_02557_5 crossref_primary_10_1016_j_ijchp_2018_06_004 crossref_primary_10_1007_s00127_019_01715_9 crossref_primary_10_1016_j_heliyon_2025_e42029 crossref_primary_10_3390_bs12010003 crossref_primary_10_1016_j_jad_2021_10_020 crossref_primary_10_1007_s10608_020_10153_w crossref_primary_10_1186_s12991_023_00474_x crossref_primary_10_1016_j_respol_2024_105078 crossref_primary_10_1177_2055217320968597 crossref_primary_10_1007_s10862_018_9648_8 crossref_primary_10_1016_S2215_0366_14_00128_X crossref_primary_10_1016_j_brainresbull_2018_12_005 crossref_primary_10_1002_hbm_26153 crossref_primary_10_1016_j_invent_2015_07_005 crossref_primary_10_1016_j_neuroscience_2021_03_018 crossref_primary_10_1159_000509732 crossref_primary_10_1002_ejp_1218 crossref_primary_10_1007_s00127_023_02488_y crossref_primary_10_3389_fpsyg_2019_02526 crossref_primary_10_1016_j_jpainsymman_2017_04_010 crossref_primary_10_1080_08964289_2024_2375205 crossref_primary_10_1007_s10548_023_00999_0 crossref_primary_10_1136_bmjopen_2014_006141 crossref_primary_10_1136_bmjopen_2018_027362 crossref_primary_10_1001_jamapsychiatry_2019_0029 crossref_primary_10_1016_j_jad_2018_04_079 crossref_primary_10_1080_09540261_2020_1764509 crossref_primary_10_18332_ejm_124941 crossref_primary_10_1016_j_jamda_2016_03_004 crossref_primary_10_1007_s11136_020_02417_5 crossref_primary_10_1186_s12888_024_05611_8 crossref_primary_10_1002_jclp_23401 crossref_primary_10_1016_j_jad_2014_05_030 crossref_primary_10_1186_s12888_024_06417_4 crossref_primary_10_1007_s10578_020_01046_w crossref_primary_10_3390_jcm11061731 crossref_primary_10_3389_fpubh_2021_562437 crossref_primary_10_1016_j_psc_2024_04_008 crossref_primary_10_1080_0284186X_2018_1445286 crossref_primary_10_1186_s12888_020_02938_w crossref_primary_10_1016_j_jpsychores_2020_110113 crossref_primary_10_3390_pharmacy12030089 crossref_primary_10_3390_cancers12061564 crossref_primary_10_1093_eurpub_ckad026 crossref_primary_10_1016_j_jad_2022_11_036 crossref_primary_10_1007_s12144_021_02031_9 crossref_primary_10_1002_da_22453 crossref_primary_10_1111_aas_13988 crossref_primary_10_1093_icvts_ivac151 crossref_primary_10_1186_s44247_024_00120_w crossref_primary_10_18632_oncotarget_21001 crossref_primary_10_1016_S2215_0366_19_30366_9 crossref_primary_10_1371_journal_pone_0127944 crossref_primary_10_1016_j_healthplace_2018_03_006 crossref_primary_10_1186_s12888_022_03783_9 crossref_primary_10_1080_16506073_2020_1795240 crossref_primary_10_3390_nu8060366 crossref_primary_10_1080_15622975_2021_2011409 crossref_primary_10_1111_jdv_14210 crossref_primary_10_1177_2167702621994545 crossref_primary_10_3390_healthcare8030287 crossref_primary_10_2196_29384 crossref_primary_10_1371_journal_pone_0213152 crossref_primary_10_1007_s10597_020_00765_7 crossref_primary_10_1016_j_wneu_2017_06_182 crossref_primary_10_1177_08850666241255328 crossref_primary_10_4274_forbes_galenos_2022_72621 crossref_primary_10_1017_S1368980016000811 crossref_primary_10_1186_s12991_020_00311_5 crossref_primary_10_1016_j_psychres_2018_07_019 crossref_primary_10_1136_bmjsem_2023_001538 crossref_primary_10_1371_journal_pone_0111498 crossref_primary_10_1002_ajmg_b_32922 crossref_primary_10_3389_fpsyt_2024_1483782 crossref_primary_10_1007_s12144_022_03987_y crossref_primary_10_1016_j_janxdis_2018_07_003 crossref_primary_10_3389_fpsyg_2021_705383 crossref_primary_10_1007_s10198_024_01696_w crossref_primary_10_1002_nop2_703 crossref_primary_10_3389_fpsyt_2021_708305 crossref_primary_10_1186_s12889_022_13966_4 crossref_primary_10_1016_j_pbb_2013_09_001 crossref_primary_10_1192_j_eurpsy_2020_81 crossref_primary_10_1038_s41393_022_00831_9 crossref_primary_10_1016_j_mhpa_2017_09_001 crossref_primary_10_1080_0284186X_2022_2119098 crossref_primary_10_1186_s12889_020_08560_5 crossref_primary_10_1016_j_jpsychores_2014_02_008 crossref_primary_10_1016_j_psychres_2020_112795 crossref_primary_10_1080_01612840_2019_1613701 crossref_primary_10_5406_21520542_38_1_03 crossref_primary_10_1080_08039488_2021_1942980 crossref_primary_10_1016_j_rpsm_2021_10_002 crossref_primary_10_1177_14034948231160633 crossref_primary_10_1016_j_invent_2016_08_004 crossref_primary_10_1186_s13102_024_00989_0 crossref_primary_10_1080_16506073_2014_921834 crossref_primary_10_1136_bmjopen_2018_021729 crossref_primary_10_1016_j_jad_2021_05_116 crossref_primary_10_1016_j_annepidem_2018_10_007 crossref_primary_10_1590_1413_82712015200307 crossref_primary_10_1371_journal_pone_0174574 crossref_primary_10_1177_10732748221125561 crossref_primary_10_1038_srep40511 crossref_primary_10_1051_e3sconf_202560803002 crossref_primary_10_1038_s41380_020_0652_5 crossref_primary_10_1177_17456916211029964 crossref_primary_10_3390_ijerph18083992 crossref_primary_10_1007_s00127_020_02022_4 crossref_primary_10_1016_j_injr_2013_09_005 crossref_primary_10_1080_16506073_2018_1533577 crossref_primary_10_1186_s12889_021_11969_1 crossref_primary_10_1007_s00408_020_00396_5 crossref_primary_10_1007_s11136_023_03461_7 crossref_primary_10_1186_s12888_018_1712_0 crossref_primary_10_1371_journal_pone_0095395 crossref_primary_10_1016_j_jad_2018_12_027 crossref_primary_10_1111_bjc_12321 crossref_primary_10_2478_prilozi_2023_0006 crossref_primary_10_1080_19315864_2017_1299267 crossref_primary_10_1080_0167482X_2021_1885026 crossref_primary_10_1186_s12888_024_05644_z crossref_primary_10_1080_16506073_2015_1015440 crossref_primary_10_1016_j_euroneuro_2017_06_001 crossref_primary_10_1016_j_psychres_2014_12_056 crossref_primary_10_1002_hbm_24802 crossref_primary_10_2340_actadv_v102_803 crossref_primary_10_3389_fphar_2023_1171985 crossref_primary_10_1007_s00296_020_04641_1 crossref_primary_10_1007_s00127_024_02777_0 crossref_primary_10_1016_j_jpsychires_2021_07_022 crossref_primary_10_1016_j_lanwpc_2024_101026 crossref_primary_10_1016_j_mefs_2018_03_002 crossref_primary_10_1111_eip_12928 crossref_primary_10_1186_s12978_019_0802_x crossref_primary_10_1016_j_genhosppsych_2019_03_001 crossref_primary_10_1097_j_pain_0000000000001575 crossref_primary_10_1007_s10597_020_00668_7 crossref_primary_10_1016_j_lanepe_2024_100870 crossref_primary_10_1186_s12888_014_0348_y crossref_primary_10_1016_j_fertnstert_2016_01_036 crossref_primary_10_1177_0305735617730425 crossref_primary_10_1016_j_leaqua_2022_101672 crossref_primary_10_1016_j_invent_2019_100247 crossref_primary_10_1111_jep_12986 crossref_primary_10_1371_journal_pone_0218860 crossref_primary_10_3389_fpsyg_2024_1259997 crossref_primary_10_1016_j_eclinm_2024_102631 crossref_primary_10_1186_s12888_020_02749_z crossref_primary_10_1111_joim_13461 crossref_primary_10_1016_j_jad_2017_03_018 crossref_primary_10_1007_s00127_018_1651_6 crossref_primary_10_1038_s44184_023_00032_z crossref_primary_10_1111_ejh_13399 crossref_primary_10_1016_j_invent_2014_08_002 crossref_primary_10_1016_S2215_0366_18_30292_X crossref_primary_10_1007_s00520_021_06517_x |
| Cites_doi | 10.1111/acps.12079 10.1016/j.jad.2008.08.014 10.1001/archpsyc.1988.01800360017003 10.1016/j.genhosppsych.2010.03.006 10.1093/oxfordjournals.aje.a116399 10.1586/erp.12.67 10.2196/jmir.1463 10.1016/j.addbeh.2007.09.017 10.1146/annurev.clinpsy.3.022806.091444 10.1016/S0140-6736(06)67964-6 10.1016/0168-8510(90)90421-9 10.1891/0889-8391.23.1.20 10.1016/j.cpr.2009.11.004 10.1001/archpsyc.62.6.617 10.1097/MLR.0b013e318160d093 10.1176/appi.ps.57.12.1738 10.1080/16506073.2010.550059 10.1023/A:1013171831202 10.1007/s00127-002-0542-y 10.1016/j.comppsych.2008.05.012 10.1002/da.1020 10.1016/j.jad.2008.06.026 10.1002/da.20256 10.1176/appi.ajp.163.1.109 10.1016/j.brat.2009.01.010 10.1016/j.genhosppsych.2005.07.003 10.1007/s001270050163 10.1016/S0005-7894(02)80026-0 10.2105/AJPH.79.8.1006 10.1017/S0033291710000176 10.1007/s00127-007-0204-1 10.1001/archinte.166.10.1092 10.1007/s001270050098 10.1348/135910703762879246 10.1097/00005650-199711000-00002 10.1037/a0017391 10.1136/bmjopen-2012-002167 10.7326/0003-4819-146-5-200703060-00004 10.1097/00019442-200501000-00006 10.1016/j.beth.2012.01.001 10.1192/bjp.156.3.336 10.3109/10550490903205652 10.1001/jama.289.23.3095 10.1371/journal.pmed.0040296 10.1002/14651858.MR000008.pub3 10.1016/j.janxdis.2009.04.006 10.1192/bjp.178.2.145 10.1046/j.1525-1497.2001.016009606.x 10.1192/bjp.bp.106.025106 10.1016/j.jad.2007.05.020 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2013 PeerJ. Ltd. 2013 Johansson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/3.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2013 Johansson et al. 2013 Johansson et al. |
| Copyright_xml | – notice: COPYRIGHT 2013 PeerJ. Ltd. – notice: 2013 Johansson et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/3.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2013 Johansson et al. 2013 Johansson et al. |
| DBID | AAYXX CITATION NPM 3V. 7XB 88I 8FE 8FH 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO GNUQQ HCIFZ LK8 M2P M7P PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM ABXSW ADTPV AOWAS D8T DG8 ZZAVC ABAVF DG7 ADTOC UNPAY DOA |
| DOI | 10.7717/peerj.98 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection Proquest Central Natural Science Collection ProQuest One ProQuest Central ProQuest Central Student Proquest SciTech Premium Collection ProQuest Biological Science Collection Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database (ProQuest) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Linköpings universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Linköpings universitet SwePub Articles full text SWEPUB Stockholms universitet full text SWEPUB Stockholms universitet Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health Psychology |
| EISSN | 2167-8359 |
| ExternalDocumentID | oai_doaj_org_article_1e0e1848cfe14633a1945c01e9d3c973 10.7717/peerj.98 oai_swepub_ki_se_528159 oai_DiVA_org_su_92823 oai_DiVA_org_liu_96837 PMC3709104 A543557651 23862109 10_7717_peerj_98 |
| Genre | Journal Article |
| GeographicLocations | Sweden |
| GeographicLocations_xml | – name: Sweden |
| GrantInformation_xml | – fundername: Linköping University |
| GroupedDBID | 53G 5VS 88I 8FE 8FH AAFWJ AAYXX ABUWG ADBBV ADRAZ AENEX AFKRA AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ CCPQU CITATION DIK DWQXO GNUQQ GROUPED_DOAJ GX1 H13 HCIFZ HYE IAO IEA IHR IHW ITC KQ8 LK8 M2P M7P M~E OK1 PHGZM PHGZT PIMPY PQGLB PQQKQ PROAC PUEGO RPM W2D YAO 3V. ECGQY M48 NPM 7XB 8FK PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM ABXSW ADTPV AOWAS D8T DG8 ZZAVC ABAVF DG7 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c675t-3998903a9a83e22dde6e5ea5e94f44e997e2bbd7b1733c80c3b2bde52f2c3aea3 |
| IEDL.DBID | BENPR |
| ISSN | 2167-8359 |
| IngestDate | Fri Oct 03 12:46:08 EDT 2025 Sun Oct 26 04:15:17 EDT 2025 Mon Oct 20 03:26:00 EDT 2025 Tue Sep 09 23:07:38 EDT 2025 Tue Sep 09 23:36:58 EDT 2025 Tue Sep 30 15:48:58 EDT 2025 Fri Jul 11 16:16:46 EDT 2025 Fri Jul 25 04:27:02 EDT 2025 Mon Oct 20 22:12:19 EDT 2025 Mon Oct 20 16:33:59 EDT 2025 Thu May 22 21:19:58 EDT 2025 Thu Jan 02 22:13:29 EST 2025 Wed Oct 01 02:43:19 EDT 2025 Thu Apr 24 23:02:55 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Health-related quality of life Depression Anxiety Prevalence Generalized anxiety disorder |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c675t-3998903a9a83e22dde6e5ea5e94f44e997e2bbd7b1733c80c3b2bde52f2c3aea3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/1959564936?pq-origsite=%requestingapplication%&accountid=15518 |
| PMID | 23862109 |
| PQID | 1959564936 |
| PQPubID | 2045935 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_1e0e1848cfe14633a1945c01e9d3c973 unpaywall_primary_10_7717_peerj_98 swepub_primary_oai_swepub_ki_se_528159 swepub_primary_oai_DiVA_org_su_92823 swepub_primary_oai_DiVA_org_liu_96837 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3709104 proquest_miscellaneous_1401092582 proquest_journals_1959564936 gale_infotracmisc_A543557651 gale_infotracacademiconefile_A543557651 gale_healthsolutions_A543557651 pubmed_primary_23862109 crossref_citationtrail_10_7717_peerj_98 crossref_primary_10_7717_peerj_98 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2013-07-09 |
| PublicationDateYYYYMMDD | 2013-07-09 |
| PublicationDate_xml | – month: 07 year: 2013 text: 2013-07-09 day: 09 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Diego – name: San Francisco, USA |
| PublicationTitle | PeerJ (San Francisco, CA) |
| PublicationTitleAlternate | PeerJ |
| PublicationYear | 2013 |
| Publisher | PeerJ. Ltd PeerJ, Inc PeerJ Inc |
| Publisher_xml | – name: PeerJ. Ltd – name: PeerJ, Inc – name: PeerJ Inc |
| References | Furmark (10.7717/peerj.98/ref-24) 1999; 34 Schoevers (10.7717/peerj.98/ref-51) 2005; 13 (10.7717/peerj.98/ref-20) 2007 Allgulander (10.7717/peerj.98/ref-4) 2003; 100 EuroQol Group (10.7717/peerj.98/ref-21) 1990; 16 Robins (10.7717/peerj.98/ref-48) 1988; 45 (10.7717/peerj.98/ref-54) 2010 Eaton (10.7717/peerj.98/ref-18) 1992; 135 Patten (10.7717/peerj.98/ref-46) 2009; 50 Kendler (10.7717/peerj.98/ref-30) 2006; 163 Allgulander (10.7717/peerj.98/ref-3) 1989; 79 Kessler (10.7717/peerj.98/ref-32) 2005; 62 Martin (10.7717/peerj.98/ref-40) 2006; 28 Munk-Jørgensen (10.7717/peerj.98/ref-43) 2006; 57 Andrews (10.7717/peerj.98/ref-6) 2001; 178 Hedman (10.7717/peerj.98/ref-26) 2012; 12 Johansson (10.7717/peerj.98/ref-29) 2012; 2 Sherbourne (10.7717/peerj.98/ref-52) 2010; 40 Ebmeier (10.7717/peerj.98/ref-19) 2006; 367 Dolan (10.7717/peerj.98/ref-16) 1997; 35 Baumeister (10.7717/peerj.98/ref-7) 2007; 42 Kessler (10.7717/peerj.98/ref-33) 2007; 3 Carpentier (10.7717/peerj.98/ref-13) 2009; 18 Newman (10.7717/peerj.98/ref-45) 2002; 33 Cloninger (10.7717/peerj.98/ref-15) 2006; 5 Albert (10.7717/peerj.98/ref-1) 2008; 105 Carlbring (10.7717/peerj.98/ref-12) 2002; 37 Kessler (10.7717/peerj.98/ref-31) 2003; 289 Pirkis (10.7717/peerj.98/ref-47) 2009; 115 Kroenke (10.7717/peerj.98/ref-37) 2007; 146 Huppert (10.7717/peerj.98/ref-28) 2003; 8 Titov (10.7717/peerj.98/ref-55) 2011; 40 Spitzer (10.7717/peerj.98/ref-53) 2006; 166 Saarni (10.7717/peerj.98/ref-50) 2007; 190 Mennin (10.7717/peerj.98/ref-42) 2009; 23 Bijl (10.7717/peerj.98/ref-9) 1998; 33 Carter (10.7717/peerj.98/ref-14) 2001; 13 Beck (10.7717/peerj.98/ref-8) 1996 Kessler (10.7717/peerj.98/ref-34) 2004 Kroenke (10.7717/peerj.98/ref-36) 2010; 32 Burström (10.7717/peerj.98/ref-10) 2001; 10 Hämäläinen (10.7717/peerj.98/ref-25) 2008; 25 Muñoz (10.7717/peerj.98/ref-44) 2010; 12 Rorsman (10.7717/peerj.98/ref-49) 1990; 156 Andersson (10.7717/peerj.98/ref-5) 2009; 47 Calear (10.7717/peerj.98/ref-11) 2009; 77 Aldao (10.7717/peerj.98/ref-2) 2010; 30 First (10.7717/peerj.98/ref-23) 1997 McEvoy (10.7717/peerj.98/ref-41) 2009; 23 Farchione (10.7717/peerj.98/ref-22) 2012; 43 Kroenke (10.7717/peerj.98/ref-38) 2009; 114 Löwe (10.7717/peerj.98/ref-39) 2008; 46 Kroenke (10.7717/peerj.98/ref-35) 2001; 16 Von Elm (10.7717/peerj.98/ref-56) 2007; 4 Dum (10.7717/peerj.98/ref-17) 2008; 33 Hedman (10.7717/peerj.98/ref-27) 2013 16413879 - Lancet. 2006 Jan 14;367(9505):153-67 20015584 - Clin Psychol Rev. 2010 Mar;30(2):217-37 9857791 - Soc Psychiatry Psychiatr Epidemiol. 1998 Dec;33(12):587-95 11301924 - Depress Anxiety. 2001;13(2):78-88 15939839 - Arch Gen Psychiatry. 2005 Jun;62(6):617-27 2346831 - Br J Psychiatry. 1990 Mar;156:336-42 18388841 - Med Care. 2008 Mar;46(3):266-74 20633738 - Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59 11157427 - Br J Psychiatry. 2001 Feb;178:145-53 12107711 - Soc Psychiatry Psychiatr Epidemiol. 2002 May;37(5):207-11 12643820 - Br J Health Psychol. 2003 Feb;8(Pt 1):107-22 23257775 - BMJ Open. 2012 Dec 19;2(6):null 19874168 - Am J Addict. 2009 Nov-Dec;18(6):470-80 1595691 - Am J Epidemiol. 1992 May 1;135(9):1051-9 17964079 - Addict Behav. 2008 Feb;33(2):381-7 16377369 - Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):71-7 16717171 - Arch Intern Med. 2006 May 22;166(10):1092-7 17443629 - Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000008 11822795 - Qual Life Res. 2001;10(7):621-35 17941714 - PLoS Med. 2007 Oct 16;4(10):e296 16390897 - Am J Psychiatry. 2006 Jan;163(1):109-14 17339617 - Ann Intern Med. 2007 Mar 6;146(5):317-25 25155813 - Cogn Behav Ther. 2011;40(2):126-36 15653938 - Am J Geriatr Psychiatry. 2005 Jan;13(1):31-9 23252357 - Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64 18817976 - J Affect Disord. 2009 May;115(1-2):54-61 2848472 - Arch Gen Psychiatry. 1988 Dec;45(12):1069-77 19230862 - Behav Res Ther. 2009 Mar;47(3):175-80 18752852 - J Affect Disord. 2009 Apr;114(1-3):163-73 9366889 - Med Care. 1997 Nov;35(11):1095-108 22697453 - Behav Ther. 2012 Sep;43(3):666-78 10501711 - Soc Psychiatry Psychiatr Epidemiol. 1999 Aug;34(8):416-24 10109801 - Health Policy. 1990 Dec;16(3):199-208 19464142 - J Anxiety Disord. 2009 Oct;23(7):866-71 19968379 - J Consult Clin Psychol. 2009 Dec;77(6):1021-32 17238158 - Depress Anxiety. 2008;25(1):27-37 17516013 - Soc Psychiatry Psychiatr Epidemiol. 2007 Jul;42(7):537-46 16946938 - World Psychiatry. 2006 Jun;5(2):71-6 2751014 - Am J Public Health. 1989 Aug;79(8):1006-10 17716051 - Annu Rev Clin Psychol. 2007;3:137-58 23406572 - Acta Psychiatr Scand. 2013 Dec;128(6):457-67 17401039 - Br J Psychiatry. 2007 Apr;190:326-32 11556941 - J Gen Intern Med. 2001 Sep;16(9):606-13 21169162 - J Med Internet Res. 2010 Dec 17;12(5):e60 20146834 - Psychol Med. 2010 Dec;40(12):2059-68 19059510 - Compr Psychiatry. 2009 Jan-Feb;50(1):26-33 12680020 - Lakartidningen. 2003 Mar 6;100(10):832-8 17617468 - J Affect Disord. 2008 Jan;105(1-3):297-303 17158488 - Psychiatr Serv. 2006 Dec;57(12):1738-44 12813115 - JAMA. 2003 Jun 18;289(23):3095-105 |
| References_xml | – year: 2013 ident: 10.7717/peerj.98/ref-27 article-title: Effectiveness of Internet-based cognitive behaviour therapy for panic disorder in routine psychiatric care publication-title: Acta Psychiatrica Scandinavica doi: 10.1111/acps.12079 – volume: 115 start-page: 54 year: 2009 ident: 10.7717/peerj.98/ref-47 article-title: The community prevalence of depression in older Australians publication-title: Journal of Affective Disorders doi: 10.1016/j.jad.2008.08.014 – volume: 45 start-page: 1069 year: 1988 ident: 10.7717/peerj.98/ref-48 article-title: The composite international diagnostic interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures publication-title: Archives of General Psychiatry doi: 10.1001/archpsyc.1988.01800360017003 – volume: 32 start-page: 345 year: 2010 ident: 10.7717/peerj.98/ref-36 article-title: The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review publication-title: General Hospital Psychiatry doi: 10.1016/j.genhosppsych.2010.03.006 – year: 2010 ident: 10.7717/peerj.98/ref-54 – volume: 135 start-page: 1051 year: 1992 ident: 10.7717/peerj.98/ref-18 article-title: Psychopathology and attrition in the epidemiologic catchment area surveys publication-title: American Journal of Epidemiology doi: 10.1093/oxfordjournals.aje.a116399 – volume: 12 start-page: 745 year: 2012 ident: 10.7717/peerj.98/ref-26 article-title: Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness publication-title: Expert Review of Pharmacoeconomics & Outcomes Research doi: 10.1586/erp.12.67 – volume: 12 start-page: e60 year: 2010 ident: 10.7717/peerj.98/ref-44 article-title: Using evidence-based internet interventions to reduce health disparities worldwide publication-title: Journal of Medical Internet Research doi: 10.2196/jmir.1463 – volume: 33 start-page: 381 year: 2008 ident: 10.7717/peerj.98/ref-17 article-title: Comparing the BDI-II and the PHQ-9 with outpatient substance abusers publication-title: Addictive Behaviors doi: 10.1016/j.addbeh.2007.09.017 – volume: 3 start-page: 137 year: 2007 ident: 10.7717/peerj.98/ref-33 article-title: Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century publication-title: Annual Review of Clinical Psychology doi: 10.1146/annurev.clinpsy.3.022806.091444 – volume: 367 start-page: 153 year: 2006 ident: 10.7717/peerj.98/ref-19 article-title: Recent developments and current controversies in depression publication-title: Lancet doi: 10.1016/S0140-6736(06)67964-6 – volume: 16 start-page: 199 year: 1990 ident: 10.7717/peerj.98/ref-21 article-title: EuroQol–a new facility for the measurement of health-related quality of life. The EuroQol Group publication-title: Health Policy doi: 10.1016/0168-8510(90)90421-9 – volume: 23 start-page: 20 year: 2009 ident: 10.7717/peerj.98/ref-41 article-title: Efficacy of transdiagnostic treatments: a review of published outcome studies and future research directions publication-title: Journal of Cognitive Psychotherapy doi: 10.1891/0889-8391.23.1.20 – volume: 30 start-page: 217 year: 2010 ident: 10.7717/peerj.98/ref-2 article-title: Emotion-regulation strategies across psychopathology: a meta-analytic review publication-title: Clinical Psychology Review doi: 10.1016/j.cpr.2009.11.004 – volume: 62 start-page: 617 year: 2005 ident: 10.7717/peerj.98/ref-32 article-title: Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication publication-title: Archives of General Psychiatry doi: 10.1001/archpsyc.62.6.617 – volume: 46 start-page: 266 year: 2008 ident: 10.7717/peerj.98/ref-39 article-title: Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population publication-title: Medical Care doi: 10.1097/MLR.0b013e318160d093 – volume: 57 start-page: 1738 year: 2006 ident: 10.7717/peerj.98/ref-43 article-title: Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden publication-title: Psychiatric Services doi: 10.1176/appi.ps.57.12.1738 – volume: 40 start-page: 126 year: 2011 ident: 10.7717/peerj.98/ref-55 article-title: Psychometric comparison of the PHQ-9 and BDI-II for measuring response during treatment of depression publication-title: Cognitive Behaviour Therapy doi: 10.1080/16506073.2010.550059 – start-page: 29 volume-title: Generalized anxiety disorder: advances in research and practice year: 2004 ident: 10.7717/peerj.98/ref-34 article-title: Epidemiology – volume: 10 start-page: 621 year: 2001 ident: 10.7717/peerj.98/ref-10 article-title: Swedish population health-related quality of life results using the EQ-5D publication-title: Quality of Life Research doi: 10.1023/A:1013171831202 – volume: 37 start-page: 207 year: 2002 ident: 10.7717/peerj.98/ref-12 article-title: 12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population publication-title: Social Psychiatry and Psychiatric Epidemiology doi: 10.1007/s00127-002-0542-y – volume: 50 start-page: 26 year: 2009 ident: 10.7717/peerj.98/ref-46 article-title: Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9) publication-title: Comprehensive Psychiatry doi: 10.1016/j.comppsych.2008.05.012 – volume: 100 start-page: 832 year: 2003 ident: 10.7717/peerj.98/ref-4 article-title: Var fjärde patient lider av ångest och depression [A nationwide study in primary health care: one out of four patients suffers from anxiety and depression] publication-title: Läkartidningen – volume: 13 start-page: 78 year: 2001 ident: 10.7717/peerj.98/ref-14 article-title: One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample publication-title: Depression and Anxiety doi: 10.1002/da.1020 – volume: 114 start-page: 163 year: 2009 ident: 10.7717/peerj.98/ref-38 article-title: The PHQ-8 as a measure of current depression in the general population publication-title: Journal of Affective Disorders doi: 10.1016/j.jad.2008.06.026 – volume: 25 start-page: 27 year: 2008 ident: 10.7717/peerj.98/ref-25 article-title: Use of health services for major depressive and anxiety disorders in Finland publication-title: Depression and Anxiety doi: 10.1002/da.20256 – volume: 163 start-page: 109 year: 2006 ident: 10.7717/peerj.98/ref-30 article-title: A Swedish national twin study of lifetime major depression publication-title: The American Journal of Psychiatry doi: 10.1176/appi.ajp.163.1.109 – volume: 47 start-page: 175 year: 2009 ident: 10.7717/peerj.98/ref-5 article-title: Using the Internet to provide cognitive behaviour therapy publication-title: Behaviour Research and Therapy doi: 10.1016/j.brat.2009.01.010 – volume: 28 start-page: 71 year: 2006 ident: 10.7717/peerj.98/ref-40 article-title: Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population publication-title: General Hospital Psychiatry doi: 10.1016/j.genhosppsych.2005.07.003 – volume: 34 start-page: 416 year: 1999 ident: 10.7717/peerj.98/ref-24 article-title: Social phobia in the general population: prevalence and sociodemographic profile publication-title: Social Psychiatry and Psychiatric Epidemiology doi: 10.1007/s001270050163 – volume: 33 start-page: 215 year: 2002 ident: 10.7717/peerj.98/ref-45 article-title: Preliminary reliability and validity of the Generalized Anxiety Disorder Questionnaire-IV: a revised self-report diagnostic measure of generalized anxiety disorder publication-title: Behavior Therapy doi: 10.1016/S0005-7894(02)80026-0 – volume: 79 start-page: 1006 year: 1989 ident: 10.7717/peerj.98/ref-3 article-title: Psychoactive drug use in a general population sample, Sweden: correlates with perceived health, psychiatric diagnoses, and mortality in an automated record-linkage study publication-title: American Journal of Public Health doi: 10.2105/AJPH.79.8.1006 – volume: 40 start-page: 2059 year: 2010 ident: 10.7717/peerj.98/ref-52 article-title: Functioning and disability levels in primary care out-patients with one or more anxiety disorders publication-title: Psychological Medicine doi: 10.1017/S0033291710000176 – volume: 42 start-page: 537 year: 2007 ident: 10.7717/peerj.98/ref-7 article-title: Prevalence of mental disorders based on general population surveys publication-title: Social Psychiatry and Psychiatric Epidemiology doi: 10.1007/s00127-007-0204-1 – volume: 166 start-page: 1092 year: 2006 ident: 10.7717/peerj.98/ref-53 article-title: A brief measure for assessing generalized anxiety disorder: the GAD-7 publication-title: Archives of Internal Medicine doi: 10.1001/archinte.166.10.1092 – volume: 33 start-page: 587 year: 1998 ident: 10.7717/peerj.98/ref-9 article-title: Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS) publication-title: Social Psychiatry and Psychiatric Epidemiology doi: 10.1007/s001270050098 – volume: 5 start-page: 71 year: 2006 ident: 10.7717/peerj.98/ref-15 article-title: The science of well-being: an integrated approach to mental health and its disorders publication-title: World Psychiatry – volume: 8 start-page: 107 year: 2003 ident: 10.7717/peerj.98/ref-28 article-title: Evidence for the independence of positive and negative well-being: implications for quality of life assessment publication-title: British Journal of Health Psychology doi: 10.1348/135910703762879246 – volume: 35 start-page: 1095 year: 1997 ident: 10.7717/peerj.98/ref-16 article-title: Modeling valuations for EuroQol health states publication-title: Medical Care doi: 10.1097/00005650-199711000-00002 – volume: 77 start-page: 1021 year: 2009 ident: 10.7717/peerj.98/ref-11 article-title: The YouthMood Project: a cluster randomized controlled trial of an online cognitive behavioral program with adolescents publication-title: Journal of Consulting and Clinical Psychology doi: 10.1037/a0017391 – volume: 2 start-page: e002167 year: 2012 ident: 10.7717/peerj.98/ref-29 article-title: Transdiagnostic, affect-focused, psychodynamic, guided self-help for depression and anxiety through the internet: study protocol for a randomised controlled trial publication-title: BMJ Open doi: 10.1136/bmjopen-2012-002167 – volume: 146 start-page: 317 year: 2007 ident: 10.7717/peerj.98/ref-37 article-title: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection publication-title: Annals of Internal Medicine doi: 10.7326/0003-4819-146-5-200703060-00004 – volume-title: Beck depression inventory-II: manual year: 1996 ident: 10.7717/peerj.98/ref-8 – volume: 13 start-page: 31 year: 2005 ident: 10.7717/peerj.98/ref-51 article-title: Depression and generalized anxiety disorder: co-occurrence and longitudinal patterns in elderly patients publication-title: The American Journal of Geriatric Psychiatry doi: 10.1097/00019442-200501000-00006 – volume: 43 start-page: 666 year: 2012 ident: 10.7717/peerj.98/ref-22 article-title: Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial publication-title: Behavior Therapy doi: 10.1016/j.beth.2012.01.001 – volume: 156 start-page: 336 year: 1990 ident: 10.7717/peerj.98/ref-49 article-title: A prospective study of first-incidence depression. The Lundby study, 1957–72 publication-title: The British Journal of Psychiatry doi: 10.1192/bjp.156.3.336 – volume: 18 start-page: 470 year: 2009 ident: 10.7717/peerj.98/ref-13 article-title: Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients publication-title: The American Journal on Addictions doi: 10.3109/10550490903205652 – volume: 289 start-page: 3095 year: 2003 ident: 10.7717/peerj.98/ref-31 article-title: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) publication-title: JAMA doi: 10.1001/jama.289.23.3095 – volume: 4 start-page: e296 year: 2007 ident: 10.7717/peerj.98/ref-56 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: PLoS Medicine doi: 10.1371/journal.pmed.0040296 – volume-title: SCID-I: structured clinical interview for DSM-IV Axis I disorders year: 1997 ident: 10.7717/peerj.98/ref-23 – year: 2007 ident: 10.7717/peerj.98/ref-20 doi: 10.1002/14651858.MR000008.pub3 – volume: 23 start-page: 866 year: 2009 ident: 10.7717/peerj.98/ref-42 article-title: Emotion regulation deficits in generalized anxiety disorder, social anxiety disorder, and their co-occurrence publication-title: Journal of Anxiety Disorders doi: 10.1016/j.janxdis.2009.04.006 – volume: 178 start-page: 145 year: 2001 ident: 10.7717/peerj.98/ref-6 article-title: Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey publication-title: The British Journal of Psychiatry doi: 10.1192/bjp.178.2.145 – volume: 16 start-page: 606 year: 2001 ident: 10.7717/peerj.98/ref-35 article-title: The PHQ-9 publication-title: Journal of General Internal Medicine doi: 10.1046/j.1525-1497.2001.016009606.x – volume: 190 start-page: 326 year: 2007 ident: 10.7717/peerj.98/ref-50 article-title: Impact of psychiatric disorders on health-related quality of life: general population survey publication-title: The British Journal of Psychiatry doi: 10.1192/bjp.bp.106.025106 – volume: 105 start-page: 297 year: 2008 ident: 10.7717/peerj.98/ref-1 article-title: Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes publication-title: Journal of Affective Disorders doi: 10.1016/j.jad.2007.05.020 – reference: 10109801 - Health Policy. 1990 Dec;16(3):199-208 – reference: 12643820 - Br J Health Psychol. 2003 Feb;8(Pt 1):107-22 – reference: 17617468 - J Affect Disord. 2008 Jan;105(1-3):297-303 – reference: 17401039 - Br J Psychiatry. 2007 Apr;190:326-32 – reference: 11301924 - Depress Anxiety. 2001;13(2):78-88 – reference: 17339617 - Ann Intern Med. 2007 Mar 6;146(5):317-25 – reference: 15939839 - Arch Gen Psychiatry. 2005 Jun;62(6):617-27 – reference: 18817976 - J Affect Disord. 2009 May;115(1-2):54-61 – reference: 9366889 - Med Care. 1997 Nov;35(11):1095-108 – reference: 20146834 - Psychol Med. 2010 Dec;40(12):2059-68 – reference: 16946938 - World Psychiatry. 2006 Jun;5(2):71-6 – reference: 18752852 - J Affect Disord. 2009 Apr;114(1-3):163-73 – reference: 16413879 - Lancet. 2006 Jan 14;367(9505):153-67 – reference: 9857791 - Soc Psychiatry Psychiatr Epidemiol. 1998 Dec;33(12):587-95 – reference: 16717171 - Arch Intern Med. 2006 May 22;166(10):1092-7 – reference: 23257775 - BMJ Open. 2012 Dec 19;2(6):null – reference: 19464142 - J Anxiety Disord. 2009 Oct;23(7):866-71 – reference: 19230862 - Behav Res Ther. 2009 Mar;47(3):175-80 – reference: 19968379 - J Consult Clin Psychol. 2009 Dec;77(6):1021-32 – reference: 18388841 - Med Care. 2008 Mar;46(3):266-74 – reference: 17964079 - Addict Behav. 2008 Feb;33(2):381-7 – reference: 11822795 - Qual Life Res. 2001;10(7):621-35 – reference: 21169162 - J Med Internet Res. 2010 Dec 17;12(5):e60 – reference: 11157427 - Br J Psychiatry. 2001 Feb;178:145-53 – reference: 12107711 - Soc Psychiatry Psychiatr Epidemiol. 2002 May;37(5):207-11 – reference: 1595691 - Am J Epidemiol. 1992 May 1;135(9):1051-9 – reference: 23406572 - Acta Psychiatr Scand. 2013 Dec;128(6):457-67 – reference: 20633738 - Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59 – reference: 22697453 - Behav Ther. 2012 Sep;43(3):666-78 – reference: 2848472 - Arch Gen Psychiatry. 1988 Dec;45(12):1069-77 – reference: 17941714 - PLoS Med. 2007 Oct 16;4(10):e296 – reference: 23252357 - Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):745-64 – reference: 16390897 - Am J Psychiatry. 2006 Jan;163(1):109-14 – reference: 19059510 - Compr Psychiatry. 2009 Jan-Feb;50(1):26-33 – reference: 16377369 - Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):71-7 – reference: 15653938 - Am J Geriatr Psychiatry. 2005 Jan;13(1):31-9 – reference: 12813115 - JAMA. 2003 Jun 18;289(23):3095-105 – reference: 11556941 - J Gen Intern Med. 2001 Sep;16(9):606-13 – reference: 19874168 - Am J Addict. 2009 Nov-Dec;18(6):470-80 – reference: 2751014 - Am J Public Health. 1989 Aug;79(8):1006-10 – reference: 17443629 - Cochrane Database Syst Rev. 2007 Apr 18;(2):MR000008 – reference: 17158488 - Psychiatr Serv. 2006 Dec;57(12):1738-44 – reference: 12680020 - Lakartidningen. 2003 Mar 6;100(10):832-8 – reference: 10501711 - Soc Psychiatry Psychiatr Epidemiol. 1999 Aug;34(8):416-24 – reference: 20015584 - Clin Psychol Rev. 2010 Mar;30(2):217-37 – reference: 17516013 - Soc Psychiatry Psychiatr Epidemiol. 2007 Jul;42(7):537-46 – reference: 25155813 - Cogn Behav Ther. 2011;40(2):126-36 – reference: 17238158 - Depress Anxiety. 2008;25(1):27-37 – reference: 17716051 - Annu Rev Clin Psychol. 2007;3:137-58 – reference: 2346831 - Br J Psychiatry. 1990 Mar;156:336-42 |
| SSID | ssj0000826083 |
| Score | 2.4333518 |
| Snippet | Background. Depression and anxiety disorders are major world-wide problems. There are no or few epidemiological studies investigating the prevalence of... |
| SourceID | doaj unpaywall swepub pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e98 |
| SubjectTerms | Algorithms Anxiety Comorbidity Depression Epidemiology Generalized anxiety disorder Health aspects Health surveys Health-related quality of life Medical research Medicine, Experimental Mental depression Mental disorders Panic attacks Prevalence Prevalence studies (Epidemiology) Psychiatry and Psychology Psychology Psykologi Public Health Quality of life SAMHÄLLSVETENSKAP Sex differences SOCIAL SCIENCES Socialvetenskap Studies Surveys |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDzwOiDeBAgYVuJA2sePY5lYoVYVULlDUm2U7Ng2ssqvtrkr_BL-ZsZ2NNlDgwimRPYnsmfF4Rp75jNCWJk1dV1rk3pR1DtaPgh1kNhfCF9IQossyFCcffqgPjqr3x-x47aqvkBOW4IET43ZKVziIQoT1DhY1pRqibmaL0smGWskjzmch5FowFW0weM3gXCS0WQ4hy87MufnXbSlG-0-E6f_dGK_tRr9mSvZ4otfQlWU30-dnejJZ24_2b6DrvSOJd9MEbqJLrruFLh_2R-W30Y-9VY5r9wrr7nvIzYRng-PRAAZFm85N24ATjtsuNOKPZ6FG9wR_SUjUeDbc7fUa3ttugeGHoJjBFqz-hFM-CJ52OFVU5rE4xjU4VWue46nHk9a7O-ho_92ntwd5f_lCbiGGWOTguAhZUC21oI4QsIK1Y04zJytfVU5K7ogxDTclp9SKwlJDTOMY8cRS7TS9iza6aefuI8wLXXjjifamrnzBdMlM8OMM99y4Smbo5UokyvbI5OGCjImCCCUIT0XhKSky9HSgnCU0jgto3gSpDv0BPzs2gFapXqvUv7QqQ0-CTqjEusEKqF0G7iWEaKyEQUeKYAdgsFb35Qww5YCoNaLcHFHC-rXj7pXeqd5-nKoA-cPqStIapjx0hy9DTlznpkugqcKxJmGCZOheUtNh0uCI1RDMA2v5SIFHXBn3dO1JRBenPLiQVYaeJ1UffbLXft6NjJy0SyVrQXmGtv5GdwpkENUDQ19cQNY3fYM3pxgR4Ftn6Nmwsv4o4wf_Q8YP0VUS7zbheSE30cZivnSPwMNcmMfRmPwE6pWAdQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKK_E48H4EChhU4EKWxI5jm9tCqSqkVkiwqJws27Fp6Cq76u6qlB_Bb2acZKNNKRWnRPEkisfj8TfyzGeEtjQp8jzTIvYmzWPwfhT8ILOxED6RhhCdpqE4eW8_3x1lHw_YwRrCy1qYlf17DpHGm6lzxz8GUlxCGzkDtL2ONkb7n4bfwplxgbIbAIRsOGV74r1Vpibj_9vlrqw5Z_MhW9bQa-jKoprq0xM9Hq-sOjs3muzHWU1WGJJNjgaLuRnYX2eoHC_q0E10vYWceNjYyC205qrb6PJeu6l-B_3eXmbDVq-xrn6GLE64FrjeRMBgkpNjUxYA13FZhYf480mo5j3E3xvOajztTgF7C_dlNcfwQTDh4DWWX8JN5gieVLipvYzrMhpX4Kau8xRPPB6X3t1Fo50PX97vxu0xDbGFaGMeA8QRMqFaakEdIeAvc8ecZk5mPsuclNwRYwpuUk6pFYmlhpjCMeKJpdppeg-tV5PKPUCYJzrxxhPtTZ75hOmUmYD4DPfcuExG6NVyWJVtOczDURpjBbFMUK-q1aukiNCzTnLa8HacI_MuWEbXHpi26wcwXqqduCp1iYMoWFjvYFGhVKcyYzZJnSyolZxG6GmwK9WorvMXasgAiEIwx1L46VoieAz4WavbwgfocuDe6klu9iRhptt-89J2VetpZiqQA7E8kzSHLnfN4c2QPVe5yQJksrABSpggEbrfmHrXaYBsOYT9oFremwQ9rfRbqvKw5iGnPIDNLEIvmunSe2W7_DqsFTkuF0rmgvIIbV0kNwMxiP9BoS_PEWsfHcGdU4wIQOERet7Nzn-O8cP_EXqErpL6lBMeJ3ITrc-PF-4xYM25edK6mz-XvYWk priority: 102 providerName: Unpaywall |
| Title | Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/23862109 https://www.proquest.com/docview/1959564936 https://www.proquest.com/docview/1401092582 https://pubmed.ncbi.nlm.nih.gov/PMC3709104 https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-96837 https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-92823 http://kipublications.ki.se/Default.aspx?queryparsed=id:130454910 https://doi.org/10.7717/peerj.98 https://doaj.org/article/1e0e1848cfe14633a1945c01e9d3c973 |
| UnpaywallVersion | publishedVersion |
| Volume | 1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2167-8359 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000826083 issn: 2167-8359 databaseCode: KQ8 dateStart: 20130101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2167-8359 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000826083 issn: 2167-8359 databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2167-8359 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000826083 issn: 2167-8359 databaseCode: DIK dateStart: 20130101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2167-8359 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000826083 issn: 2167-8359 databaseCode: GX1 dateStart: 20130101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2167-8359 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000826083 issn: 2167-8359 databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2167-8359 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000826083 issn: 2167-8359 databaseCode: RPM dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2167-8359 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000826083 issn: 2167-8359 databaseCode: BENPR dateStart: 20130212 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdGJ_HxgPgmMIZBA14IS-w4sZEQ6tjGhLRqAorKk2Un9haoktK1Gvsn-Js554sFxl7ayL5Eyfl8vrPvfofQhiJZHEeK-1aHsQ_aj4IeZKnPuQ2EJkSFoUtO3h_Fe-Pow4RNVtCozYVxYZWtTqwUdVambo9804GgsDgSNH47--G7qlHudLUtoaGa0grZmwpi7BJaJQ4Za4BWt3ZGBx-7XRdY8GIwOmoU2gRcmc2ZMfNvrwTvrUsVfP-_SvrMKvV3BGWDM3oNXVkWM3V6oqbTM-vU7g10vTEw8bCWiJtoxRS30OX95gj9Nvq13ca-Fi-xKn66mE34z3B1ZICBGeVc5xkY5zgvXCP-dOJyd4_wYY1QjWddza_XcJ0XCwwPBIF1OqJ9Eq7jRHBZ4DrT0q-SZkyG6yzOU1xaPM2tuYPGuzuf3-35TVEGPwXfYuGDQcNFQJVQnBpCQDvGhhnFjIhsFBkhEkO0zhIdJpSmPEipJjozjFiSUmUUvYsGRVmY-wgngQqstkRZHUc2YCpk2tl3OrGJNpHw0It2SGTaIJa7whlTCZ6LGzxZDZ4U3ENPOspZjdJxDs2WG9Wu3-FqVw3l_FA201SGJjDg8_LUGlhCKFWhiFgahEZkNBUJ9dBjJxOyZl2nHeSQgdkJrhsL4aUrCqcf4GVT1aQ5wCc7pK0e5VqPEuZ12u9u5U42euVY_pkF8Mldt7vTxcoVplwCTeSOOwnjxEP3ajHtPhoMtBjmBbA26Qlwjyv9niI_qlDHaeJMy8hDz2pR792ynX8ZVoyc5kspYk4TD21cRHcMZODtA0Ofn0PWNH2HKyMZ4WBze-hpN7P-O8YPLubZQ3SVVNVMEj8Qa2iwmC_NI7ApF3q9URTr1Z4M_L6fhNA2Hh0Mv_4G1IaC0g |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bTtVAcIOQiD4Y71ZRVgP6YqXdS7trQgwIBuQSo2B4W3fbLVRP2uPhnCA_4Sf5bc72JlXkjac2u9OmOzM7l-5cEFrQJI0ipoWfmTDyQfpRkIM88YXIAmkI0WHokpN3dqONffb-gB9MoV9tLowLq2xlYiWo0zJx_8iXXBEUHjFJozfD777rGuVOV9sWGrpprZAuVyXGmsSOLXt6Ai7c8fLmGtB7kZB363tvN_ymy4CfgLE89kFDCxlQLbWglhDY7pHlVnMrWcaYlTK2xJg0NmFMaSKChBpiUstJRhKqrabw3itohlEmwfmbWV3f_fCx-8sDCjYCI6euehuD67Q0tHb09ZUUPT1YtQv4Vymc0Yp_R2w2dU2vo9lJMdSnJ3owOKMX391ENxqDFq_UHHgLTdniNrq60xzZ30E_19pY2-Il1sUPFyMK1xRXRxQYkF-OTJ6CM4Dzwg3iTycuV_gIH9YVsfGw6zH2Gu7zYozhhbBBnExq34TruBRcFrjO7PSrJB2b4jpr9BSXGR7kmb2L9i-FPPfQdFEW9gHCcaCDzGREZyZiWcB1yI2zJ02cxcYy6aEXLUlU0lRId406Bgo8JUc8VRFPSeGhpx3ksK4Kcg7MqqNqN-_qeFcD5ehQNWJBhTaw4GOLJLOgsijVoWQ8CUIrU5rImHpo3vGEqlHXSSO1wsHMBVeRh_DRFYSTR_CxiW7SKmDJrrJXD3KuBwlyJOlPt3ynGjl2rP7sOlhyN-2edLF5hS0nAMPc8Srhgnjofs2m3aLBIIwIzHoo7jFwDyv9mSI_qqqc09iZssxDizWr9x5Zyz-vVIgc5BMlI0FjDy1cBHcMYEQQQOjzc8CaoW9wZxUnAmx8Dz3rdtZ_afzwYpzNo9mNvZ1ttb25u_UIXSNVJ5XYD-Qcmh6PJvYx2LNj86QRGhh9uWw59Rssrb2c |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dT9UwFG8QEtQH47dTlGpAX5x3a_fRmhADXgiIEKJieKvt1sH0Zrvej1z5J_zD_Ks83brJFHnjaUt7tqw97e-cs54PhFYkSaMokMzNlB-5gH4UcDBMXMYyjytCpO-b4OS9_Wj7MHh3FB7NoV9NLIxxq2wwsQLqtEzMP_KeSYISRgGnUS-zbhEH_a03w--uqSBlTlqbchrSlllI16p0YzbIY1efzsCcG6_t9IH3q4RsbX56u-3aigNuAorzxAVpzbhHJZeMakJg60c61DLUPMiCQHMea6JUGis_pjRhXkIVUakOSUYSKrWk8N4raMEcfgFILGxs7h98aP_4gLCNQOGpM-DGYEb1hlqPvr7irCMTq9IB_wqIMxLyb-9Nm-P0Oro6LYbydCYHgzMycusmumGVW7xer8ZbaE4Xt9Hinj2-v4N-9hu_2-IllsUP4y8K1xRXxxUYGFGOVJ6CYYDzwjTijzMTN3yCj-vs2HjY1ht7Dfd5McHwQtgsBp-aN-HaRwWXBa6jPN0qYEenuI4gPcVlhgd5pu-iw0thzz00X5SFfoBw7EkvUxmRmYqCzAulHyqjW6o4i5UOuINeNCwRic2Wbop2DARYTYZ5omKe4MxBT1vKYZ0h5ByaDcPVtt_k9K4aytGxsBAhfO1psLdZkmkQX5RKnwdh4vmapzThMXXQslkTop66FpnEeggqL5iNoQ8fXVEYbIKPTaQNsYAhmyxfHcqlDiVgStLtbtadsJg2Fn92IAy57TZPGj-9QpdToAnMUSsJGXHQ_XqZtoMG5TAi0OuguLOAO7PS7SnykyrjOY2NWhs4aLVe6p1H-vnn9WoiB_lU8IjR2EErF9GNgYwwAhP6_Bwy2_QN7rQICQN930HP2p31Xx4_vHjOltEi4JV4v7O_-whdI1VRldj1-BKan4ym-jGothP1xGIGRl8uG6Z-A4xNwcs |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKK_E48H4EChhU4EKWxI5jm9tCqSqkVkiwqJws27Fp6Cq76u6qlB_Bb2acZKNNKRWnRPEkisfj8TfyzGeEtjQp8jzTIvYmzWPwfhT8ILOxED6RhhCdpqE4eW8_3x1lHw_YwRrCy1qYlf17DpHGm6lzxz8GUlxCGzkDtL2ONkb7n4bfwplxgbIbAIRsOGV74r1Vpibj_9vlrqw5Z_MhW9bQa-jKoprq0xM9Hq-sOjs3muzHWU1WGJJNjgaLuRnYX2eoHC_q0E10vYWceNjYyC205qrb6PJeu6l-B_3eXmbDVq-xrn6GLE64FrjeRMBgkpNjUxYA13FZhYf480mo5j3E3xvOajztTgF7C_dlNcfwQTDh4DWWX8JN5gieVLipvYzrMhpX4Kau8xRPPB6X3t1Fo50PX97vxu0xDbGFaGMeA8QRMqFaakEdIeAvc8ecZk5mPsuclNwRYwpuUk6pFYmlhpjCMeKJpdppeg-tV5PKPUCYJzrxxhPtTZ75hOmUmYD4DPfcuExG6NVyWJVtOczDURpjBbFMUK-q1aukiNCzTnLa8HacI_MuWEbXHpi26wcwXqqduCp1iYMoWFjvYFGhVKcyYzZJnSyolZxG6GmwK9WorvMXasgAiEIwx1L46VoieAz4WavbwgfocuDe6klu9iRhptt-89J2VetpZiqQA7E8kzSHLnfN4c2QPVe5yQJksrABSpggEbrfmHrXaYBsOYT9oFremwQ9rfRbqvKw5iGnPIDNLEIvmunSe2W7_DqsFTkuF0rmgvIIbV0kNwMxiP9BoS_PEWsfHcGdU4wIQOERet7Nzn-O8cP_EXqErpL6lBMeJ3ITrc-PF-4xYM25edK6mz-XvYWk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Depression%2C+anxiety+and+their+comorbidity+in+the+Swedish+general+population&rft.jtitle=PeerJ+%28San+Francisco%2C+CA%29&rft.au=Johansson%2C+Robert&rft.au=Carlbring%2C+Per&rft.au=Heedman%2C+%C3%85sa&rft.au=Paxling%2C+Bj%C3%B6rn&rft.date=2013-07-09&rft.issn=2167-8359&rft.eissn=2167-8359&rft.volume=1&rft_id=info:doi/10.7717%2Fpeerj.98&rft.externalDocID=oai_DiVA_org_su_92823 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2167-8359&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2167-8359&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2167-8359&client=summon |